s-nitroso-n-acetylpenicillamine has been researched along with Mast-Cell Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albina, JE; Mateo, RB; Reichner, JS | 1 |
1 other study(ies) available for s-nitroso-n-acetylpenicillamine and Mast-Cell Sarcoma
| Article | Year |
|---|---|
NO is not sufficient to explain maximal cytotoxicity of tumoricidal macrophages against an NO-sensitive cell line.
Topics: Animals; Cattle; Cell Death; Cells, Cultured; Cytotoxicity, Immunologic; Humans; Lipopolysaccharides; Lymphocyte Activation; Macrophage Activation; Macrophages; Male; Mast-Cell Sarcoma; Mice; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Rats; Rats, Inbred F344; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Sensitivity and Specificity; Tumor Necrosis Factor-alpha; Vasodilator Agents; Wounds and Injuries | 1996 |